Mobile |
Deutsch |
Español |
Français |
日本語 |
한국어 |
Português |
Русский |
中文 |
العربية |
PATENTSCOPE
Search International and National Patent Collections
Options
Query
Result
Interface
Office
Translate
«
↓
»
Query Language
All
English
Hebrew
Korean
Spanish
Vietnamese
Arabic
Estonian
Indonesian
Polish
Swedish
Chinese
French
Italian
Portuguese
Swedish
Danish
German
Japanese
Russian
Thai
Stem
Sort by:
Relevance
Pub Date Desc
Pub Date Asc
App Date Desc
App Date Asc
List Length
10
50
100
200
Result List Language
Query Language
Vietnamese
German
Italian
Arabic
Swedish
English
Hebrew
Japanese
Polish
Estonian
Spanish
Portuguese
Russian
Danish
Indonesian
Korean
French
Chinese
Swedish
Thai
Displayed Fields
Application Number
Abstract
Int. Class
Inventor Name
Publication Date
Applicant Name
Image
Chart/Graph
Table
Graph
Group by
None
IPC code
Inventors
Publication Dates
Offices of NPEs
Applicants
Filing Dates
Countries
No of Items/Group
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
Download Fields
NPEs
Default Search Form
Simple
Advanced Search
Field Combination
Browse by Week (PCT)
Cross Lingual Expansion
Translator
Default Tab Search Form
Front Page
Any Field
Full Text
ID/Numbers
IPC
Names
Dates
Interface Language
English
Deutsch
Français
Español
日本語
中文
한국어
Português
Русский
Skins
Default
Plain
Blue_Sky
Classic
Deep_Marine
Emerald_Town
Japan_Cherry
Ruby
Wine
Multiple Windows Interface
Tooltip Help
IPC Tooltip Help
Office:
All
All
PCT
Africa
ARIPO
Egypt
Kenya
Morocco
Tunisia
South Africa
Americas
United States of America
Canada
LATIPAT
Argentina
Brazil
Chile
Colombia
Costa Rica
Cuba
Dominican Rep.
Ecuador
El Salvador
Guatemala
Honduras
Mexico
Nicaragua
Panama
Peru
Uruguay
Asia-Europe
Australia
Bahrain
China
Denmark
Estonia
Eurasian Patent Office
European Patent Office
France
Germany
Germany(DDR data)
Israel
Japan
Jordan
Portugal
Russian Federation
Russian Federation(USSR data)
Saudi Arabia
United Arab Emirates
Spain
Republic of Korea
India
United Kingdom
Georgia
Asean
Singapore
Viet Nam
Indonesia
Cambodia
Malaysia
Brunei Darussalam
Philippines
Thailand
WIPO translate (Wipo internal translation tool)
Search
Simple
Advanced Search
Field Combination
Cross Lingual Expansion
Browse
Browse by Week (PCT)
Gazette Archive
Download National Phase Entries
Sequence listing
IPC Green Inventory
Portal to patent registers
Translate
WIPO Translate
WIPO Pearl
Options
Sort
Graph
Show Options
News
PATENTSCOPE News
Login
Login
Account Sign Up
Help
How to Search
User Guide PATENTSCOPE
User Guide: Cross Lingual Expansion
User Guide: ChemSearch
Query Syntax
Fields Definition
Country Code
Data Coverage
PCT applications
PCT national phase entry
National collections
Global Dossier public
FAQ
Feedback&Contact
INID codes
Kind codes
Tutorials
About
Overview
Terms And Conditions
Disclaimer
Home
IP Services
PATENTSCOPE
Machine translation
Wipo Translate
Arabic
German
English
Spanish
French
Japanese
Korean
Portuguese
Russian
Chinese
Google Translate
Bing/Microsoft Translate
Baidu Translate
Arabic
English
French
German
Spanish
Portuguese
Russian
Korean
Japanese
Chinese
...
Italian
Thai
Cantonese
Classical Chinese
1. (WO2017177828) NOVEL OXAZOLIDINONE-FLUOROQUINOLONE DERIVATIVE AND USES
PCT Biblio. Data
Full Text
National Phase
Notices
Drawings
Documents
«
↓
»
Latest bibliographic data on file with the International Bureau
⇨
Submit observation
PermaLink
PermaLink
Bookmark
Pub. No.:
WO/2017/177828
International Application No.:
PCT/CN2017/078798
Publication Date:
19.10.2017
International Filing Date:
30.03.2017
IPC:
C07D 498/06
(2006.01),
C07D 513/04
(2006.01),
C07D 513/06
(2006.01),
C07D 513/14
(2006.01),
C07D 471/06
(2006.01),
A61K 31/5395
(2006.01),
A61K 31/5383
(2006.01),
A61K 31/4745
(2006.01),
A61K 31/542
(2006.01),
A61K 31/4985
(2006.01),
A61K 31/4545
(2006.01)
C
CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
498
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
02
in which the condensed system contains two hetero rings
06
Peri-condensed systems
C
CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
513
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/, C07D477/232
02
in which the condensed system contains two hetero rings
04
Ortho-condensed systems
C
CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
513
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/, C07D477/232
02
in which the condensed system contains two hetero rings
06
Peri-condensed systems
C
CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
513
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/, C07D477/232
12
in which the condensed system contains three hetero rings
14
Ortho-condensed systems
C
CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
471
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/-C07D463/251
02
in which the condensed system contains two hetero rings
06
Peri-condensed systems
A
HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
535
having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
5395
having two or more nitrogen atoms in the same ring, e.g. oxadiazines
A
HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
535
having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
5375
1,4-Oxazines, e.g. morpholine
5383
ortho- or peri-condensed with heterocyclic ring systems
A
HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
47
Quinolines; Isoquinolines
4738
ortho- or peri-condensed with heterocyclic ring systems
4745
condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenanthrolines
A
HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
54
having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame
542
ortho- or peri-condensed with heterocyclic ring systems
A
HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
4985
Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
A
HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
445
Non-condensed piperidines, e.g. piperocaine
4523
containing further heterocyclic ring systems
4545
containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
Applicants:
LI, Jing
[US/CN]; (CN)
Inventors:
LI, Jing
; (CN).
CUI, Haifeng
; (CN).
LV, Pengyue
; (CN).
DAI, Baohua
; (CN).
PEI, Yuning
; (CN)
Agent:
JUN HE LAW OFFICES
; 20/F, China Resources Building 8 Jianguomenbei Avenue Beijing 100005 (CN)
Priority Data:
201610220830.4
12.04.2016
CN
Title
(EN)
NOVEL OXAZOLIDINONE-FLUOROQUINOLONE DERIVATIVE AND USES
(FR)
NOUVEAU DÉRIVÉ D’OXAZOLIDINONE-FLUOROQUINOLONE ET SES UTILISATIONS
(ZH)
新型噁唑烷酮-氟喹诺酮衍生物及用途
Abstract:
(EN)
The present invention relates to a novel oxazolidinone-fluoroquinolone derivative and uses, and relates to the field of chemical drugs. The present invention also relates to a compound represented by formula (I), a pharmaceutically acceptable optical raceme, a stereoisomer, a salt, a solvate, a hydrate or a prodrug thereof, and applications of a pharmaceutical composition thereof in prevention or treatment of infections (such as a bacterial infection). They are effective antimicrobial agents and can effectively resist against multiple pathogens on human bodies and animals, and the pathogens comprise but are not limited to gram-positive bacteria, gram-negative bacteria, anaerobic microorganisms and acidotolerant microorganisms.
(FR)
La présente invention se rapporte à un nouveau dérivé d’oxazolidinone-fluoroquinolone et à ses utilisations et concerne le domaine des médicaments chimiques. La présente invention se rapporte également à un composé représenté par la formule (I), un racémique optique, un stéréoisomère, un sel, un solvate, un hydrate ou un promédicament pharmaceutiquement acceptables de ce dernier et à des applications d’une composition pharmaceutique le contenant en prévention ou traitement d’infections (telles qu’une infection bactérienne). Ce sont des agents antimicrobiens efficaces et ils peuvent résister efficacement à de multiples pathogènes sur des corps humains et des animaux et les pathogènes comprennent, sans limitation, les bactéries à Gram positif, les bactéries à Gram négatif, les micro-organismes anaérobies et les micro-organismes acido-tolérants.
(ZH)
本发明涉及一种新型噁唑烷酮-氟喹诺酮衍生物及用途,属于化学药物领域。如式(I)所述化合物,或其药学上可接受的光学消旋体、立体异构体、盐、溶剂合物、水合物或前药,及其药物组合物在预防或治疗感染(例如细菌感染)中的应用。它们是有效的抗微生物剂,能够有效抵抗多种人和动物病原体,所述病原体包括但不仅限于革兰氏阳性细菌、革兰氏阴性细菌、厌氧微生物及耐酸微生物。
Designated States:
AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language:
Chinese (
ZH
)
Filing Language:
Chinese (
ZH
)